Pharma Journalist -

UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug (AED) BRIVIACT …
Read More...

Zymeworks Inc. and Daiichi Sankyo announced that they entered into a new license agreement, building upon their 2016 cross-licensing and collaboration agreement. “With a successful…
Read More...

Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora kinase A…
Read More...

Medigene AG announced the significant expansion of its successful strategic alliance with bluebird bio, a leader in gene and cell therapies, focusing on the research and development of…
Read More...

Quality Packaging Specialists Int'l (QPSI) and Supply Chain Wizard announced their newly formed partnership, supporting QPSI's mission to digitally refine their US-based factory network…
Read More...

FUJIFILM Holdings Corporation (President: Kenji Sukeno) announced it plans to merge TOYAMA CHEMICAL CO., LTD., a company that conducts the research, development, manufacture, and sales…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with…
Read More...

SMi Group reports on preparations for SMi's inaugural Immuno-Oncology Conference, which is scheduled to take place 26 - 27 September in London. The official programme of…
Read More...

In just 3 weeks, SMi Group will open its doors to host the next instalment in this year’s PFS conference series, 3rd annual Pre-Filled Syringes West Coast (June 4 – 5, San Diego).…
Read More...

The U.S. Food and Drug Administration, in two complaints filed in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without…
Read More...